Andrew Badrot, Founder and CEO
Holds an MS in Engineering Economics Systems and Operations Research from Stanford University, California, USA and an Engineering Degree in Nuclear Physics from Institut Polytechnique in Grenoble, France.
Prior positions:
- Vice President of Strategy, Exclusive Synthesis sector; Lonza AG
Basel, Switzerland (2007-2010) - Project leader in Corporate Strategy; Schott AG
Mainz, Germany (2005-2007) - Senior Manager, Business Development and Strategy; Sun Microsystems
Menlo Park, California, USA (2001-2004) - Business Development; Buildfolio.com
Palo Alto, California, USA (2000-2001) - Nuclear Engineer; Schlumberger
Houston, Texas, USA (1998)
--
Michèle Schüepp, Senior Consultant
Holds an MS in Science, Business and Chemistry from the University of Zürich, Switzerland.
Prior positions:
- Strategy & Special Projects, Exclusive Synthesis sector; Lonza AG
Basel, Switzerland (2008-2010) - Master Thesis in cooperation with Lonza on the Evaluation of the Indian Pharmaceutical Market
Basel, Switzerland (2010)
--
Board Member: Dr. Peter Pollak
Holds a PhD in Chemical Engineering from the Swiss Federal Institute of Technology in Zürich. Published an industry reference book: Fine Chemicals – The Industry and the Business, John Wiley, New York, 2007
- Member of the Advisory Board of CMS Pharma (2010 - present)
- Board member and advisory board member of various of small to medium sized fine chemical companies worldwide, including Hikal Ltd (1999 - present)
- Self-employed Fine Chemicals Business Consultant (1999 - present)
- Created, developed and ran Lonza’s Fine Chemicals / Custom Manufacturing Business (1968-1999)
- Senior VP & GM Fine Chemicals at Lonza’s US headquarters (1995-1998)
- R&D chemist and production manager at Lonza’s Ftalital site, Bergamo, Italy (1962-1968)
--
Partnership: Dr. Vanya Loroch
CEO of Loroch Communication & Training in Life Sciences - Read More...
--